GLP1R and diabetes mellitus: In type 2 diabetes mellitus which is characterized by increased non-enzymatic protein glycosylation because of chronic hyperglycemia, GLP-1R agonists might also improve defective glucose transport and glycometabolic control by stimulating AMPK phosphorylation.